Zynerba Press Releases

14 Sep 23 Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium

14 Aug 23 HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.

8 Aug 23 Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting

25 Jul 23 Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting

28 Jun 23 Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meeting

20 Jun 23 Zynerba Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference

13 Jun 23 Zynerba Pharmaceuticals Announces Partial Adjournment of Annual Meeting

23 May 23 Zynerba Pharmaceuticals Announces Podium and Poster Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

15 May 23 Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights

12 Apr 23 Zynerba Pharmaceuticals Presents Data on Zygel™ at the 55th Gatlinburg Conference